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Abstract
Objective: To determine whether a series of diseases of the oral mucosa - Sjögren syndrome, ectodermal dysplasia, 
epidermolysis bullosa and lichen planus - reduce the survival rate of dental implants.
Material and Method: A Medline search was carried out using the key words: “Sjögren syndrome”, “ectodermal 
dysplasia”, “epidermolysis bullosa”, “lichen planus” and “dental implants”, including those publications involving 
clinical series comprising more than one patient with the mentioned disorders and treated with dental implants, 
in the last 10 years. 
Results: The study included three articles involving patients with Sjögren syndrome subjected to dental implant 
treatment, representing a total of 12 patients and 86 implants, with a mean pondered success rate of 86.33%. 
As regards ectodermal dysplasia, we included 14 articles, of which 11 corresponded to clinical series, two were 
reviews and one constituted a survey of dental professionals. The percentage success rate of the implants varied 
between 35.7-100%. In relation to epidermolysis bullosa, we included 6 articles corresponding to clinical series, 
with a total of 16 patients and 92 implants, and a success rate between 75-100%. In the case of oral lichen planus 
we found only two articles corresponding to clinical case series, with a total of 5 patients and 14 implants, and an 
implant survival rate of 100%. 
Conclusions: Based on our review of the literature, dental implant rehabilitation in patients of this kind is seen to 
be a valid treatment option, with a high percentage success rate. Long-term patient follow-up is essential in order 
to periodically monitor the condition of the disease and of the implants.
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Introduction
Dental implants are increasingly used to replace missing 
teeth, and offer a percentage success rate of close to 90-95% 
after 10 years. The literature contains many references to 
contraindications of implant treatment in patients with sys-
temic diseases, though in some instances such contraindi-
cations appear to be only theoretical (1). Systemic diseases 
can affect the oral tissues, increasing the susceptibility to 
other pathologies or interfering with the healing processes. 
In addition, the management of such disorders with drugs 
or other therapies can affect the dental implants or the oral 
tissues supporting them (2).
While some systemic diseases and oral mucosal disor-
ders commonly have been regarded as contraindications 
for the placement of implants, the benefits of such treat-
ment in these patients sometimes outweigh the risks. 
The present study examines whether these alterations of 
the oral mucosa, such as Sjögren syndrome, ectodermal 
dysplasia, epidermolysis bullosa and oral lichen planus 
(OLP), are able to directly influence dental implant sur-
vival. To this effect, a literature review has been made 
to assess the possible influence of these oral mucosal 
disorders upon implant stability and failure.
Sjögren syndrome is a chronic systemic autoimmune 
disease affecting the exocrine glands, particularly the 
salivary and lacrimal glands, with the development of 
hyposialia that adversely affects patient quality of life 
(3). Ectodermal dysplasia in turn comprises a group of 
genetic disorders including congenital defects of two or 
more ectodermal structures such as the skin, hair, nails, 
nerve cells, sweat glands and parts of the eyes and ears 
(4-7). These patients present severe oligodontia or ano-
dontia - dental implants being the treatment of choice in 
both adults and in patients during the growth phase (8,9). 
Hereditary epidermolysis bullosa comprises a group of 
hereditary diseases of the skin and mucosal membranes, 
characterized by the development of blisters and vesi-
cles in response to minimum friction or trauma (10-17). 
Lastly, lichen planus is a chronic inflammatory disease 
of the skin and mucosas that evolves in the form of out-
breaks or flare-ups (18). 
A Medline search was carried out using the key words: 
“Sjögren syndrome”, “ectodermal dysplasia”, “epider-
molysis bullosa”, “lichen planus” and “dental implants”, 
including those publications involving clinical series 
comprising more than one patient with the mentioned 
disorders and treated with dental implants, in the last 10 
years. The study finally included four articles on Sjögren 
syndrome, 15 articles on ectodermal dysplasia, and 8 ar-
ticles on epidermolysis bullosa and oral lichen planus.
Sjögren Syndrome
Sjögren syndrome is a chronic systemic autoimmune 
disease affecting the exocrine glands, particularly the 
salivary and lacrimal glands, and characterized by the 
appearance of a lymphocytic inflammatory infiltrate 
that interferes with gland function. There are two clini-
cal forms of the syndrome, a primary presentation char-
acterized by keratoconjunctivitis sicca and hyposialia, 
and a secondary presentation which in addition to these 
two clinical signs also presents connective tissue dis-
ease – usually in the form of rheumatoid arthritis or sys-
temic lupus erythematosus. Sjögren syndrome is one of 
the three most frequent autoimmune disorders, together 
with systemic lupus erythematosus and systemic scle-
rosis. It affects 0.5-3% of the population, and is more 
prevalent in women than in men (9:1 proportion) (3).
Patients with Sjögren syndrome have speech, chewing 
and swallowing difficulties, with dry mouth sensation 
or xerostomia – this being the manifestation with the 
greatest impact upon patient quality of life. The disease 
is also characterized by taste alterations, and burning 
sensation or pain in the salivary glands related with the 
ingestion of food. The clinical signs in turn comprise 
hyposialia, cracked, dry and desquamative lips, and a 
dry, dirty, erythematous and cracked tongue. Also very 
common is the association of angle cheilitis, rampant 
caries in atypical locations, occlusal wear or attrition, 
gland swelling, mucositis and oral ulcerations. Chronic 
erythematous candidiasis due to Candida albicans is 
seen in 70-80% of the patients, affecting the tongue, 
palate and lip commissures (3).
Patients with Sjögren syndrome and dental implants
Patients with Sjögren syndrome suffer xerostomia, 
which often causes them to reject wearing conventional 
removable dentures, due to poor retention and severe 
difficulties associated with their presence in the mouth. 
It has been proposed that these patients may benefit 
from prostheses with artificial saliva reservoirs, which 
could reduce the unpleasant sensation produced by the 
removable dentures (19). In any case, treatment with 
dental implants is presently the most widely accepted 
solution.
Three studies involving implants in patients with Sjö-
gren syndrome with long-term follow-up have been 
found in the literature (Table 1). Payne et al. (20) placed 
26 implants in three patients, with an 88.4% success 
rate. Isidor et al. (19) reported an 84% success rate af-
ter four years of follow-up in 8 women with implant-
retained removable dentures. After two years, the pa-
tients reported a high degree of satisfaction. Binon (21) 
controlled one patient with Sjögren syndrome during 13 
years, rehabilitated with a fixed prosthesis over 6 im-
plants, and reported a 100% success rate.
In patients with secondary Sjögren syndrome and ad-
vanced rheumatoid arthritis, careful evaluation is re-
quired of their degree of manual dexterity, considering 
the movement limitations of these patients, in order to 
ascertain that they are able to properly maintain oral 
hygiene after treatment with prostheses over implants. 
Med Oral Patol Oral Cir Bucal. 2011 Sep 1;16 (6):e787-93.                                                                                                                                                           Implants and oral mucosal alterations
e789
The severity of Sjögren syndrome and the medical com-
plications of the patient must be evaluated before rec-
ommending the routine placement of implants (20).
Ectodermal Dysplasia
Anhidrotic ectodermal dysplasia comprises a group of 
genetic disorders including congenital defects of two or 
more ectodermal structures such as the skin, hair, nails, 
nerve cells, sweat glands and parts of the eyes and ears 
(4-7).
The disease is relatively rare, with a frequency of be-
tween 1:10,000 and 1:100,000 live births, and is more 
common in males than in females. Other authors report 
an incidence of 1-7:100,000 (8). In most cases the dis-
order shows a recessive autosomal hereditary pattern, 
though dominant autosomal or chromosome X-linked 
forms are also observed (2).
The diagnosis of patients with ectodermal dysplasia 
is fundamentally based on the clinical history (ungual 
dystrophy, hypotrichosis, anodontia, oligodontia, hypo-
dontia); a skin biopsy in cases with perspiration altera-
tions (reduction in the number of pilosebaceous units 
and sweat glands); the presence of fine and thin hair; 
a panoramic X-ray study (revealing dental morphologi-
cal alterations and agenesis); and a molecular genetic 
analysis.
At oral cavity level, ectodermal dysplasia is character-
ized by the observation of anodontia and hypodontia of 
the temporal and permanent dentition, impacted teeth, 
pin-type dental malformations, enamel hypoplasia, 
multiples diastemas and under-developed alveolar ridg-
es. These problems give rise to aesthetic and functional 
problems, and difficulties for supporting conventional 
prostheses (4-8).
In recent years treatment with dental implants has been 
offered for patients with ectodermal dysplasia, since 
they are compatible with correct development of the 
maxillofacial skeletal structures and improve prosthet-
ic stability. However, it may prove difficult to achieve 
adequate primary stability with the conventional tech-
niques – bone grafts or implants in abutments being re-
quired in such situations (4,8,22).
Ectodermal dysplasia and dental implants
Age at placement of implants and growth
Due to the anatomical characteristics of patients with 
ectodermal dysplasia who present severe oligodontia 
or anodontia, dental implant placement is the treatment 
of choice both in adults and in patients in the growth 
phase. This improves both aesthetics and function, with 
improved patient quality of life (8,9). 
In growing patients, conventional prostheses may have 
a negative effect (8), with an adverse psychological im-
pact for the patients (5). In these subjects, early treat-
ment with dental implants can offer the possibility of 
correct development of speech, chewing and swallow-
ing, allowing normal facial and temporomandibular 
joint development, and improving patient self-esteem 
(5). In the consensus conference on the dental treatment 
of children with ectodermal dysplasia, held in Sweden 
in 1998, treatment with implants was accepted in pa-
tients from 6-7 years of age.
The main problem in these patients is the change in 
the position and angulation of the implants, as well as 
their ankylosis (4-6, 23). When treating children with 
dental implants, due consideration is required of both 
the patient growth stage and the number and location of 
missing teeth (4,5,23). If the patient is partially edentu-
lous, the existing teeth stimulate vertical growth of the 
alveolar ridge, resulting in implant ankylosis. For this 
reason Imirzalioglu et al. (5) recommend the postpone-
ment of implant placement to 12 years of age in partially 
edentulous patients, while in totally edentulous children 
placement can be indicated from the age of three years 
(5,6).
As regards the location of the implants, their interforam-
inal placement is recommended by most authors (4-6), 
due to the “v”-form growth of the mandible, which re-
sults in minimal changes in the position of the implants. 
In the upper maxilla the age at placement is postponed 
to 17 years, when growth has practically ceased (4,6). 
Guckes et al. (6) recommends interconsultation with 
the orthodontist to ensure that growth has effectively 
stopped.
On the other hand, Percinoto et al. (24) do not recom-
mend treatment in growing children, except in very se-
vere cases of ectodermal dysplasia.
Type of prosthesis
Most authors use fixed or removable dentures, placed 
3-4 months after implant placement in the mandible, 
and 5-6 months after implant placement in the upper 
maxilla. Guckes et al. (6) recommend overdentures in 
AUTHOR PATIENTS AGE SEX IMPLANTS % SUCCESS FOLLOW-UP 
Payne 1997 3 38-40 Women 26 88.4 2 years 
Isidor 1999 8 53-70 Women 54 84 4 years 
Binon 2005 1 67 Male 6 100 13 years 
Table 1. Published series of implants in patients with Sjögren syndrome.
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growing children, since the prosthesis is easier to adjust 
as a consequence of the continuous wear attributable to 
growth and the occlusal changes.
Grafts and ectodermal dysplasia
The main problem in patients of this kind is the limited 
amount of bone, particularly in the upper arch. 
In the present review it was found that when patients 
presented scant bone volume, bone grafting and/or si-
nus lift procedures were carried out (4,5,8) without 
penalizing percentage success. Imirzalioglu et al. (5) 
recommended treatment with implants as soon as pos-
sible in order to prevent further bone loss over time and 
the need for bone grafting. These authors presented two 
clinical cases: bone grafting and implant placement 
were carried out in one of them (a 14-year-old boy), 
while orthognathic surgery and implant placement were 
carried out in the other (a 17-year-old boy) – with cor-
rect functioning in both patients.
Garagiola et al. (25), after comparing the success of 
guided bone regeneration with bone grafting plus mem-
brane placement in patients with ectodermal dysplasia, 
concluded that both techniques offer the same degree of 
osteointegration.
Percentage success
The implant success criteria used in patients with ecto-
dermal dysplasia were the absence of symptoms in the 
form of periimplantitis, bleeding or suppuration, a high 
probe depth, inflammation and mobility (4,6).
The percentage success of implant treatment ranged 
from 35.7-95% (Table 2). Bergendal et al. (9) obtained 
a 35.7% success rate after placing 33 implants in 21 pa-
tients between 5-12 years of age. These authors attribu-
ed the low success rate to the small size of the mouth 
and scant bone volume in these patients.
The success rates in the upper maxilla were lower than 
in the mandible. In a series of 14 patients with ectoder-
mal dysplasia, Sweeney et al. (4) carried out upper maxi-
llary rehabilitation in patients between 17-20 years of 
age, and mandibular rehabilitation in those between 12-
20 years of age – with a success rate of 80% in the maxi-
lla and 91.3% in the mandible. In turn, Guckes et al. (6), 
after treating 51 patients with 264 implants, concluded 
that implant placement in the upper maxilla has a 2.8-
fold greater probability of failure than in the mandible.
In a review published by Yap et al. (7), the percentage 
success rate was found to be 88.5-97.6%, and tended to 
decrease when implants were placed in patients under 
18 years of age. Similar results were reported by Guckes 
et al. (6), who found the percentage success rate in pa-
tients under 18 years of age to be 85-87%, versus 95% 
in those over 18 years of age.
Epidermolysis Bullosa 
Hereditary epidermolysis bullosa comprises a group 
of hereditary diseases of the skin and mucosal mem-
branes, with the development of blisters and vesicles in 
response to minimum friction or trauma. The disorder 
in turn is classified into three major categories (simple, 
junctional and dystrophic) according to the level of tis-
sue rupture following trauma, and 25 subtypes (10-17).
The oral manifestations of epidermolysis bullosa are re-
peated blistering, the formation of scars, limitation of 
oral aperture, ankyloglossia, disappearance of the oral 
and vestibular sulci, perioral stenosis, severe periodon-
tal disease and bone reabsorption, atrophy of the up-
per maxilla with mandibular prognathism, an increased 
mandibular angle, and a predisposition to oral carcino-
ma. Routine brushing can produce blistering of the oral 
mucosa (10-17). In some cases rampant caries are ob-
served in combination with hypoplastic dental enamel 
and poor oral hygiene (25).
Epidermolysis bullosa and dental implants
Totally edentulous patients with epidermolysis bullosa 
are candidates for dental implant treatment, since con-
ventional prostheses cause mucosal irritation and tissue 
friction, with blistering and tissue rupture (12). Our re-
        AUTHOR PATIENTS IMPLANTS % SUCCESS 
Kargul et al. 2001 3 - 100 
Imirzaliogli et al. 2002 3 4 100 
Guckes et al. 2002 51 264 91 mandible 76 maxilla 
Oczakir et al. 2005 4 - 100 
Sweeney et al. 2005 14 61 67.2 
Garagiola et al. 2008 33 186 100 
Bergendal et al. 2008 21 33 35.7 
Gill et al. 2008 - - - 
Carmichael et al. 2008 - - - 
Fotso et al. 2009 2 - 100 
Kirmeier et al. 2009 2 28 100 
Table 2. Published series of implants in patients with ectodermal dysplasia.
Med Oral Patol Oral Cir Bucal. 2011 Sep 1;16 (6):e787-93.                                                                                                                                                           Implants and oral mucosal alterations
e791
view of the literature yielded 6 clinical series of patients 
with epidermolysis bullosa treated with implants. In 
these studies, 16 patients were rehabilitated with a total 
of 92 implants and a success rate of 75-100% (Table 3).
The intervention in patients of this kind is complicated 
due to the formation of bleeding blisters in response to 
minimal trauma such as incision or flap raising (10-17). 
In addition, if implants are placed we have the added 
problem of the need for irrigation with saline solution, 
which must be aspirated - and aspirator contact with the 
mucosal membranes produces blistering.
Surgery is carried out under local anesthesia in most 
cases (10-13), injecting the solution slowly in order to 
avoid tissue damage, since general anesthesia poses the 
added problem of possible ulcerations caused by intuba-
tion. However, Lee et al. (14) have carried out surgery 
under general anesthesia.
In patients with important upper maxillary atrophy, the 
implants are placed using osteotomes, since conven-
tional drilling could destroy the residual bony process 
and thus reduce primary retention of the implant. Dri-
lling and irrigation are only used to create a minimum 
aperture in the residual process to allow access with 
small-diameter osteotomes (10-13). In contrast, in the 
mandible, surgical drills are required with minimum ir-
rigation and placing the aspirator in contact with bone 
instead of soft tissues. Even so, mucosal blistering ap-
pears at mandibular level (10-13). During surgery con-
tinuous patient lip lubrication is required, taking care 
with lateral traction upon the cheek, in order to avoid 
wounds and blisters (10-13).
According to the reviewed literature, in totally eden-
tulous patients the implants were placed in the sector 
anterior, due to problems of accessibility caused by the 
patient microstomia.
The follow-up period ranged from 12-108 months, and 
13 patients (86.7%) developed oral ulcerations in areas 
of friction with the prostheses. In no cases were periim-
plant mucosal alterations or blisters around the implant 
observed.
The quality of life of these patients improved consider-
ably, and they were able to chew and swallow correctly. 
Peñarrocha et al. (11) compared the degree of satisfac-
tion among patients rehabilitated with fixed prostheses 
versus those rehabilitated with overdentures, recording 
a score of 9.6 and 8.8, respectively.
All the authors concluded that the use of dental implants 
in patients with epidermolysis bullosa is appropriate, 
with a high success rate, and offering adequate support 
for the prosthesis (10-12, 14,18) (Table 3).
Oral Lichen Planus 
Oral lichen planus (OLP) is a chronic inflammatory di-
sease of the skin and mucosal membranes that evolves 
in the form of outbreaks or flare-ups. It affects 0.2-1.9% 
of the population and is more common in women. The 
age range of the affected patients is 30-70 years. The 
etiology underlying OLP is not clear (26). Clinically, the 
disease is characterized by papular and reticular lesions 
that tend to alternate with areas of erythema and atro-
phy, and exhibit a certain dynamism. In the oral muco-
sa, lichen planus can adopt varied clinical forms (26).
Silverman et al. (27) proposed dividing the disease into 
reticular, atrophic and erosive forms, while Bagán et 
al. (28) have simplified classification by considering 
two forms: a) exclusively white reticular lesions, and b) 
atrophic or ulcerative lesions with or without reticular 
lesions. These latter forms produce symptoms such as 
itching or burning sensation.
Mignogma et al. (29) applied a patient monitoring pro-
AUTHOR PATIENTS AGE IMPLANTS 
FOLLOW-UP
(months) 
% SUCCESS PROSTHESIS 
Peñarrocha M, 2007  3 29-49 27 12-60 97.7 Fixed 
Peñarrocha M, 2000  4 26-35 15 12-58 100 Overdenture 
Peñarrocha M, 2007  6 23-44 38 12-108 97.9 Fixed Overdenture 
Lee H, 2007  1 29 8 - 75 Fixed 
Larrazabal C, 2009  1 52 2 12 100 Fixed 
Oliveira, 2010 1 13 2 48 100 Fixed 
Table 3. Published series of implants in patients with epidermolysis bullosa.
AUTHOR PATIENTS AGE IMPLANTS 
FOLLOW-UP
(months) 
PROSTHESIS TYPE 
Esposito, 2003 2 72 and 78 4 21 Overdenture Erosive 
Reichart, 2006  3 63-79 10 36 Unit and bridges Reticular and atrophic 
Table 4. Published series of implants in patients with oral lichen planus – all with 100% success rates after the stated period of follow-up.
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tocol involving visits every four months during 12 years 
in 45 patients with oral lichen planus who developed 
117 malignant neoplastic events. With this protocol 
they detected 94.9% of the carcinomas in an early stage 
(intraepithelial or microinvasive) – achieving survival 
rates after 3 and 5 years of 100% and 96.7%, respective-
ly. The authors recommended control of these patients 
twice a year.
Oral lichen planus and dental implants
The great majority of contraindications for the place-
ment of dental implants are related to the quantity and 
quality of the alveolar bone, and very few are related 
to the gums and the alveolar mucosa (30). It has been 
suggested that in these patients the capacity of the epi-
thelium to adhere to the titanium surface of the implant 
is altered (31).
Despite the generalized use of dental implants, the lite-
rature documents only 5 cases of implant placement in 
patients with oral lichen planus (31,32). These 5 patients 
received a total of 14 implants, with a success rate of 
100% (Table 4).
Esposito et al. (31) found that the placement of dental 
implants for the fitting of overdentures reduced the inci-
dence of erosive lesions, and increased patient comfort 
and oral function. These patients require special care 
such as removal of the prosthesis during the two weeks 
after implant placement, and the application of topical 
corticosteroids.
It should be remembered that oral lichen planus is a pre-
cancerous condition, and that although the malignant 
transformation rate generally does not exceed 1% (32), 
the possibility of malignization must be taken into ac-
count, monitoring both the lesions derived from OLP 
and the condition of the dental implants.
Based on our review of the literature, rehabilitation with 
implants in patients of this kind is a valid treatment op-
tion, with a success rate of 86.33% in patients with Sjö-
gren syndrome, 35.2-100% in patients with ectodermal 
dysplasia, 96.75% in patients with epidermolysis bu-
llosa, and 100% in patients with OLP.
Long-term controls are essential to ensure adequate 
follow-up of the disease and of the dental implants.
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